Leland Gershell
Stock Analyst at Oppenheimer
(4.53)
# 286
Out of 5,008 analysts
142
Total ratings
50.75%
Success rate
27.51%
Average return
Main Sectors:
Stocks Rated by Leland Gershell
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRNX Crinetics Pharmaceuticals | Maintains: Outperform | $73 → $87 | $42.50 | +104.71% | 8 | Sep 30, 2025 | |
| TECX Tectonic Therapeutic | Initiates: Outperform | $80 | $14.91 | +436.55% | 1 | Sep 3, 2025 | |
| XERS Xeris Biopharma Holdings | Maintains: Outperform | $7 → $8 | $8.28 | -3.38% | 3 | Aug 8, 2025 | |
| VRDN Viridian Therapeutics | Maintains: Outperform | $28 → $32 | $21.00 | +52.38% | 6 | Aug 7, 2025 | |
| SLNO Soleno Therapeutics | Maintains: Outperform | $105 → $110 | $62.11 | +77.11% | 9 | Aug 7, 2025 | |
| BBIO BridgeBio Pharma | Maintains: Outperform | $60 → $61 | $54.22 | +12.50% | 3 | Aug 6, 2025 | |
| ALNY Alnylam Pharmaceuticals | Upgrades: Outperform | $490 | $459.58 | +6.62% | 8 | Aug 4, 2025 | |
| LXEO Lexeo Therapeutics | Initiates: Outperform | $20 | $8.34 | +139.81% | 1 | Jul 31, 2025 | |
| RYTM Rhythm Pharmaceuticals | Maintains: Outperform | $76 → $110 | $99.83 | +10.19% | 2 | Jul 10, 2025 | |
| CAPR Capricor Therapeutics | Maintains: Outperform | $43 → $22 | $7.50 | +193.33% | 5 | Jun 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $215 → $224 | $209.84 | +6.75% | 12 | Jun 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $10 → $31 | $16.83 | +84.19% | 11 | Jun 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $10 | $1.65 | +506.06% | 1 | Jun 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $704 → $708 | $797.35 | -11.21% | 7 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $10 | $1.78 | +461.80% | 1 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $20 | $9.55 | +109.42% | 3 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $98 | $54.70 | +79.16% | 3 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $48 → $52 | $34.70 | +49.86% | 2 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $50 | $4.35 | +1,049.43% | 8 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $0.21 | - | 2 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $47 → $53 | $16.11 | +228.99% | 3 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $30 | $7.01 | +327.96% | 2 | Sep 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $12 | $2.34 | +412.82% | 2 | Sep 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $30,000 → $5,000 | $7.02 | +71,125.07% | 9 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $30 → $25 | $4.82 | +418.67% | 3 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $14 → $20 | $3.39 | +489.97% | 5 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $29 | $20.82 | +39.29% | 3 | Jun 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $35 | $13.48 | +159.64% | 2 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $10 | $0.75 | +1,229.08% | 1 | Apr 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $20 | $0.96 | +1,974.26% | 3 | Nov 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $16 → $13 | $2.08 | +525.00% | 3 | Apr 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $150 → $120 | $3.44 | +3,388.37% | 1 | Mar 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $9.07 | - | 1 | Oct 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Perform | n/a | $20.07 | - | 2 | Nov 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $50 | $1.86 | +2,588.17% | 1 | Oct 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Perform | n/a | $19.27 | - | 5 | Mar 31, 2020 |
Crinetics Pharmaceuticals
Sep 30, 2025
Maintains: Outperform
Price Target: $73 → $87
Current: $42.50
Upside: +104.71%
Tectonic Therapeutic
Sep 3, 2025
Initiates: Outperform
Price Target: $80
Current: $14.91
Upside: +436.55%
Xeris Biopharma Holdings
Aug 8, 2025
Maintains: Outperform
Price Target: $7 → $8
Current: $8.28
Upside: -3.38%
Viridian Therapeutics
Aug 7, 2025
Maintains: Outperform
Price Target: $28 → $32
Current: $21.00
Upside: +52.38%
Soleno Therapeutics
Aug 7, 2025
Maintains: Outperform
Price Target: $105 → $110
Current: $62.11
Upside: +77.11%
BridgeBio Pharma
Aug 6, 2025
Maintains: Outperform
Price Target: $60 → $61
Current: $54.22
Upside: +12.50%
Alnylam Pharmaceuticals
Aug 4, 2025
Upgrades: Outperform
Price Target: $490
Current: $459.58
Upside: +6.62%
Lexeo Therapeutics
Jul 31, 2025
Initiates: Outperform
Price Target: $20
Current: $8.34
Upside: +139.81%
Rhythm Pharmaceuticals
Jul 10, 2025
Maintains: Outperform
Price Target: $76 → $110
Current: $99.83
Upside: +10.19%
Capricor Therapeutics
Jun 23, 2025
Maintains: Outperform
Price Target: $43 → $22
Current: $7.50
Upside: +193.33%
Jun 13, 2025
Maintains: Outperform
Price Target: $215 → $224
Current: $209.84
Upside: +6.75%
Jun 13, 2025
Maintains: Outperform
Price Target: $10 → $31
Current: $16.83
Upside: +84.19%
Jun 6, 2025
Initiates: Outperform
Price Target: $10
Current: $1.65
Upside: +506.06%
May 9, 2025
Maintains: Outperform
Price Target: $704 → $708
Current: $797.35
Upside: -11.21%
Mar 24, 2025
Initiates: Outperform
Price Target: $10
Current: $1.78
Upside: +461.80%
Mar 11, 2025
Maintains: Outperform
Price Target: $12 → $20
Current: $9.55
Upside: +109.42%
Feb 24, 2025
Upgrades: Outperform
Price Target: $98
Current: $54.70
Upside: +79.16%
Nov 11, 2024
Maintains: Outperform
Price Target: $48 → $52
Current: $34.70
Upside: +49.86%
Nov 5, 2024
Reiterates: Outperform
Price Target: $50
Current: $4.35
Upside: +1,049.43%
Nov 4, 2024
Downgrades: Perform
Price Target: n/a
Current: $0.21
Upside: -
Oct 9, 2024
Maintains: Outperform
Price Target: $47 → $53
Current: $16.11
Upside: +228.99%
Sep 24, 2024
Reiterates: Outperform
Price Target: $30
Current: $7.01
Upside: +327.96%
Sep 12, 2024
Reiterates: Outperform
Price Target: $12
Current: $2.34
Upside: +412.82%
Sep 3, 2024
Maintains: Outperform
Price Target: $30,000 → $5,000
Current: $7.02
Upside: +71,125.07%
Aug 12, 2024
Maintains: Outperform
Price Target: $30 → $25
Current: $4.82
Upside: +418.67%
Jul 10, 2024
Maintains: Outperform
Price Target: $14 → $20
Current: $3.39
Upside: +489.97%
Jun 6, 2024
Reiterates: Outperform
Price Target: $29
Current: $20.82
Upside: +39.29%
Apr 16, 2024
Upgrades: Outperform
Price Target: $35
Current: $13.48
Upside: +159.64%
Apr 9, 2024
Maintains: Outperform
Price Target: $10
Current: $0.75
Upside: +1,229.08%
Nov 15, 2023
Maintains: Outperform
Price Target: $23 → $20
Current: $0.96
Upside: +1,974.26%
Apr 12, 2023
Maintains: Outperform
Price Target: $16 → $13
Current: $2.08
Upside: +525.00%
Mar 24, 2023
Maintains: Outperform
Price Target: $150 → $120
Current: $3.44
Upside: +3,388.37%
Oct 4, 2022
Downgrades: Perform
Price Target: n/a
Current: $9.07
Upside: -
Nov 25, 2020
Initiates: Perform
Price Target: n/a
Current: $20.07
Upside: -
Oct 23, 2020
Initiates: Outperform
Price Target: $50
Current: $1.86
Upside: +2,588.17%
Mar 31, 2020
Upgrades: Perform
Price Target: n/a
Current: $19.27
Upside: -